WellDoc, a healthcare behavioral science and technology company that develops solutions aimed at engaging patients and enhancing health outcomes, is focused on simplifying the way chronic diseases are managed through a collaborative, life-changing approach that breaks down the barriers of engagement and adherence by providing patients and their healthcare providers with real-time, actionable information. WellDoc has developed an industry-leading, technology-based platform designed to help people with chronic diseases better manage their conditions. Forbes selected WellDoc as one of 'America's Most Promising Companies' based on its potential for future growth.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/10/14 | $20,000,000 | Strategic |
Merck Global Health Innovation Fund Windham Venture Partners | undisclosed |
| 12/18/15 | $22,000,000 | Series B |
Adage Capital Management Alexandria Real Estate Equities Excel Venture Management Hudson River Capital Partners Merck Global Health Innovation Fund Samsung Venture Investment | undisclosed |
